Other substances

Lypressin

A polypeptide vasopressin derivative.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Lypressin on PubChem

Marketed as

DIAPID

 

Structure image - Lypressin

C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N

Supporting references

Link Tested on Impact factor Notes Publication date
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Spike protein 3CLpro In silico 		in silico 4.07

Predicted to bind the SARS-CoV-2 spike protein.

 Sep/07/2020

AI-suggested references

Link Publication date
SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
Jul/23/2020
Export (.csv)